Current structural biology of the heparin interactome

Xu, 2014, Demystifying heparan sulfate–protein interactions, Annu Rev Biochem, 83, 129, 10.1146/annurev-biochem-060713-035314 Ori, 2011, A systems biology approach for the investigation of the heparin/heparan sulfate interactome, J Biol Chem, 286, 19892, 10.1074/jbc.M111.228114 Casu, 2014, Re-visiting the structure of heparin, Carbohydr Res, 403C, 60 Santos, 2014, Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs, Drug Discov Today, 19, 1801, 10.1016/j.drudis.2014.07.004 Rivera, 2011, Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombosponding domain-containing proteins, Ann Biomed Eng, 39, 2213, 10.1007/s10439-011-0325-2 Roper, 2012, Syndecan and integrin interactomes: large complexes in small spaces, Curr Opin Struct Biol, 22, 583, 10.1016/j.sbi.2012.07.003 Peyssel, 2014, Heparin–protein interactions: from affinity and kinetics tobiological roles, Application to an interaction network regulating angiogenesis, Matrix Biol, 35, 73, 10.1016/j.matbio.2013.11.001 Spiller, 2015, Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds, Biomaterials, 37, 194, 10.1016/j.biomaterials.2014.10.017 Kufareva, 2015, Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies, Immunol Cell Biol, 93, 372, 10.1038/icb.2015.15 Schlorke, 2012, The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils, Carbohydr Res, 356, 196, 10.1016/j.carres.2012.02.025 Möbius, 2013, Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach, Glycobiology, 23, 1260, 10.1093/glycob/cwt062 Seo, 2013, Differentiation of CC vs CXC chemokine dimers with GAG octasaccharide binding partners: an ion mobility mass spectrometry approach, J Am Chem Soc, 135, 4325, 10.1021/ja310915m Laguri, 2011, 13C-labeled heparan sulfate analogue as a tool to study protein/heparan sulfate interactions by NMR spectroscopy: application to the CXCL12α chemokine, J Am Chem Soc, 133, 9642, 10.1021/ja201753e Ziarek, 2013, Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus, J Biol Chem, 288, 737, 10.1074/jbc.M112.394064 Poluri, 2013, Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer, J Biol Chem, 288, 25143, 10.1074/jbc.M113.492579 Severin, 2010, Characterization of the chemokine CXCL11–heparin interaction suggests two different affinities for glycosaminoglycans, J Biol Chem, 285, 17713, 10.1074/jbc.M109.082552 Saesen, 2013, Insights into the mechanism by which interferon-γ basic amino acid clusters mediate protein binding to heparan sulfate, J Am Chem Soc, 135, 9384, 10.1021/ja4000867 Künze, 2014, NMR characterization of the binding properties and conformation of glycosaminoglycans interacting with interleukin-10, Glycobiology, 24, 1036, 10.1093/glycob/cwu069 Zhao, 2010, Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans, Biochemistry, 49, 7012, 10.1021/bi100549y Sadir, 2001, Characterization of the stromal cell-derived factor-1α–heparin complex, J Biol Chem, 276, 8288, 10.1074/jbc.M008110200 Amara, 1999, Stromal cell-derived factor-1α associates with heparan sulfates though the first β-strand of the chemokine, J Biol Chem, 274, 23916, 10.1074/jbc.274.34.23916 Sadir, 2004, Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV, J Biol Chem, 279, 43854, 10.1074/jbc.M405392200 Murphy, 2007, Structural and functional basis of CXCL12 (stromal cell-derived factor-1α) binding to heparin, J Biol Chem, 282, 10018, 10.1074/jbc.M608796200 Kurzbach, 2014, Compensatory adaptations of structural dynamics in an intriscially disordered protein complex, Angew Chem Int Ed, 53, 3840, 10.1002/anie.201308389 Cress, 2014, Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules, FEMS Microbiol Rev, 38, 660, 10.1111/1574-6976.12056 Blaum, 2010, Lysine and arginine side chains in glycosaminoglycan–protein complexes investigated by NMR, cross-linking, and mass spectrometry: a case study of the factor H–heparin interaction, J Am Chem Soc, 132, 6374, 10.1021/ja1000517 García-Mayoral, 2010, NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics, Biophys J, 98, 2702, 10.1016/j.bpj.2010.02.039 García-Mayoral, 2013, Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMR, ACS Chem Biol, 18, 144, 10.1021/cb300386v Seo, 2010, Interaction of human β-defensin 2 (HBD2) with glycosaminoglycans, Biochemistry, 49, 10486, 10.1021/bi1011749 de Paula, 2014, Unique properties of human β-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site, J Biol Chem, 289, 22969, 10.1074/jbc.M114.572529 Chabrol, 2012, Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode, PLoS One, 7, e50722, 10.1371/journal.pone.0050722 Munoz-Garcia, 2015, Langerin–heparin interaction: two binding sites for small and large ligands as revealed by a combination of NMR spectroscopy and cross-linking mapping experiments, J Am Chem Soc, 137, 4100, 10.1021/ja511529x Huntington, 2013, Thrombin inhibition by the serpins, J Thromb Haemost, 11, 254, 10.1111/jth.12252 Guerrini, 2013, An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence, Biochem J, 449, 343, 10.1042/BJ20121309 Viskov, 2013, Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties, J Biol Chem, 288, 25895, 10.1074/jbc.M113.485268 Dementiev, 2013, The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D, J Biol Chem, 288, 33611, 10.1074/jbc.M113.510727 Brown, 2013, Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes, Biophys J, 104, 1720, 10.1016/j.bpj.2013.02.051 Mohammadi, 2005, A protein canyon in the FGF–FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs, Curr Opin Struct Biol, 15, 506, 10.1016/j.sbi.2005.09.002 Xu, 2014, Homogeneous low-molecular-weight heparins with reversible anticoagulant activity, Nat Chem Biol, 10, 248, 10.1038/nchembio.1459 Liu, 2014, Chemoenzymatic synthesis of heparan sulfate and heparin, Nat Prod Rep, 31, 1676, 10.1039/C4NP00076E Zulueta, 2013, Synthetic heparin and heparan sulfate oligosaccharides and their protein interactions, Curr Opin Chem Biol, 17, 1023, 10.1016/j.cbpa.2013.10.008 Hu, 2012, Divergent synthesis of 48 heparan sulfate-based disaccharides and probing the specific sugar-fibroblast growth factor-1 interaction, J Am Chem Soc, 134, 20722, 10.1021/ja3090065 Li, 2014, Interactions that influence the binding of synthetic heparan sulfate based disaccharides to fibroblast growth factor-2, Chem Biol, 9, 1712 Yu, 2014, Characterization of heparin–protein interaction by saturation transfer difference (STD) NMR, Anal Bioanal Chem, 406, 3079, 10.1007/s00216-014-7729-4 Muñoz-García, 2013, 3D structure of a heparin mimetic analogue of a FGF-1 activator. A NMR and molecular modelling study, Org Biomol Chem, 11, 8269, 10.1039/c3ob41789a Muñoz-García, 2014, Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1, Glycobiology, 24, 1004, 10.1093/glycob/cwu071 Thacker, 2014, Heparan sulfate 3-O-sulfation: a rare modification in search of a function, Matrix Biol, 35, 60, 10.1016/j.matbio.2013.12.001 Nieto, 2011, Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor, Chemistry, 17, 11204, 10.1002/chem.201101000 Nieto, 2013, Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. A 3D view by using NMR, Chembiochem, 14, 10.1002/cbic.201300313 Platonova, 2014, Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography, PLoS One, 9, e110055, 10.1371/journal.pone.0110055 Whalen, 2013, Structural insights into proteoglycan-shaped Hedgehog signalling, Proc Natl Acad Sci, 110, 16420, 10.1073/pnas.1310097110 Lim, 2013, Structure–function analysis of full-length midkine reveals novel residues important for heparin binding and zebrafish embryogenesis, Biochem J, 451, 407, 10.1042/BJ20121622 Madine, 2012, Site-specific identification of an aβ fibril–heparin interaction site by using solid-state NMR spectroscopy, Angew Chem Int Ed Engl, 51, 13140, 10.1002/anie.201204459 Vieira, 2011, Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species, J Am Chem Soc, 133, 334, 10.1021/ja106725p Ellett LJ, Coleman BM, Shambrook MC, Johanssen VA, Collins SJ, Masters CL, Hill AF, Lawson VA: Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates. Glycobiology 2015, in press. Wang, 2012, Solution structure of decorin-binding protein A from Borrelia burgdorferi, Biochemistry, 51, 8353, 10.1021/bi3007093 Morgan, 2013, The novel heparin-binding motif in decorin-binding protein A from strain B31 of Borrelia burgdorferi explains the higher binding affinity, Biochemistry, 52, 8237, 10.1021/bi401376u Lebrun, 2012, Differential contribution of the repeats to heparin binding of HBHA, a major adhesin of Mycobacterium tuberculosis, PLoS One, 7, e32421, 10.1371/journal.pone.0032421 Bechara, 2013, Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis, FASEB J, 27, 738, 10.1096/fj.12-216176 Canales, 2005, Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor, FGF-1 recognizes both the 1C4 and 2S0 conformations of a bioactive heparin-like hexasaccharide, J Am Chem Soc, 127, 5778, 10.1021/ja043363y